Women and MDMA: particularities of gender and sex.
Fabio Carezzato, Ilana Falcão de Arruda, Caio Petrus Monteiro Figueiredo, João Maurício Castaldelli-Maia
International review of psychiatry (Abingdon, England) January 1, 2023 DOI: 10.1080/09540261.2023.2250867 via PubMed
Summary
AI-generated from the abstractGender and sex differences shape how people use MDMA and how it affects them. Women often use MDMA to cope with negative emotions or self-medicate after traumatic life events, while men are more likely to start using due to peer pressure or sensation-seeking. Women report greater anxiety, adverse effects, and negative side effects from MDMA, and they face higher risks of sexually transmitted infections because of altered mental states and reduced condom use. Women may be more susceptible to hyponatremia but less vulnerable to MDMA-induced hyperthermia. Prenatal MDMA exposure may cause motor delays in infants. MDMA-assisted psychotherapy shows promise for treating PTSD, especially in female subgroups. More research is needed to develop tailored treatments.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Addiction |
| Keywords | 3,4-methylenedioxy-methamphetamine Gender Women |
| Citations | 4 |
| Key finding | Gender and sex significantly influence patterns of MDMA use, subjective effects, and health risks, with women experiencing greater adverse effects and unique vulnerabilities, while MDMA-assisted psychotherapy shows promise for PTSD in female subgroups. |
Abstract
This comprehensive review delves into the intricate interplay between gender/sex and MDMA use, drawing upon recent evidence. It explores how girls, as a means of coping with negative emotions, often resort to drug use, while boys primarily initiate drug use due to peer pressure or sensation-seeking tendencies. Women, frequently having endured traumatic life events, may turn to MDMA as a form of self-medication. Notably, women face an elevated risk of contracting sexually transmitted infections due to their altered mental states and diminished condom use during MDMA consumption. Additionally, females exhibit heightened sensitivity to the subjective effects of MDMA, consistently reporting heightened anxiety, adverse effects, and negative side effects. While women may have a higher susceptibility to hyponatremia, intriguingly, they appear to be less vulnerable to MDMA-induced hyperthermia. Although limited, available data suggest that prenatal MDMA exposure could lead to motor delays in infants, necessitating further research to unravel the potential cognitive effects. Furthermore, MDMA-assisted psychotherapy holds immense promise for addressing post-traumatic stress disorder (PTSD) among female subgroups. These pronounced gender and sex disparities in MDMA use and its effects underscore the pressing need for additional research to develop tailored, effective, and safe treatment approaches that account for these fundamental factors.